In addition the panel is in contact with the ENS panel to facilitate future joined activities. During the last years the panel produced several guidelines: 1.
Guidelines on the use of anti-interferon-beta antibody measurements in multiple sclerosis 2. Guidelines for treatment of multiple sclerosis relapses The guidelines were published in the European Journal of Neurology in and constituted chapters in the Handbook of Neurological Management published in The Subspecialty Scientific Panel has planned to form a working group for producing a paper on the access for neurologists in all European countries to prescribe all approved immunomodulatory drugs.
Ron Milo was appointed leader of this working group. Future work of the panel will address a consensus for safety considerations for MS therapy with monoclonal antibodies. In addition, the issue of neutralizing antibodies against natalizumab will be addressed under the leadership of Prof Sorensen. Finally an update on the use of modern oral therapies for treatment of multiple sclerosis will be prepared.
Home Organisation Scientific Panels Multiple sclerosis. Multiple sclerosis.
Management Group. Individual panel members. The Baltic states Only one study from the Baltic States, a prevalence study in Southern Estonia in , was included [ ]. Discussion This systematic review has comprehensively catalogued the incidence and prevalence of MS across Europe between January and January , and unlike prior systematic reviews [ - ] of this region, has summarized methodologies and evaluated study quality using an objective measure and a predetermined set of criteria.
Conclusion While there was marked variability in the methodological quality of the studies reviewed, we can report that methods seem to have improved over time, as demonstrated by the trend towards higher quality scores in later studies. Competing interests The authors declare that they have no competing interests.
Incidence and prevalence of multiple sclerosis in Europe: a systematic review
Click here for file 38K, pdf. Additional file 2: Quality assessment form. Click here for file K, pdf. Click here for file K, doc. Acknowledgements Thanks to Ms. References World Health Organization. Atlas multiple sclerosis resources in the world Geneva: WHO Press; The accuracy of prevalence rates of multiple sclerosis: a critical review.
European Committee for Treatment and Research in Multiple Sclerosis
Environmental factors and multiple sclerosis. The Lancet Neurology. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. Temporal trends in the incidence of multiple sclerosis: a systematic review. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Sex ratio of multiple sclerosis and clinical phenotype. Eur J Neurol. Geographical variations in sex ratio trends over time in multiple sclerosis.
PLoS One. Multiple sclerosis in time and space—geographic clues to cause. J Neurovirol. Incidence and Prevalence of Multiple Sclerosis in the Americas: a systematic review. Rom J Neurol Psychiat. Prevalence of multiple sclerosis in Lanzarote Canary Islands Neurology. Epidemiological survey of multiple sclerosis in Catania city. Ital J Neurol Sci. Multiple sclerosis in Spain: an epidemiological study of the Alcoy health region, Valencia. Acta Neurol Scand.
Multiple sclerosis in Malta in an update. J Neurol Neurosurg Psychiatry. Prevalence of Multiple Sclerosis in Gypsies and Bulgarians. Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway. J Neurol. Familial clustering of multiple sclerosis in a northern Swedish rural district. Multiple sclerosis in western Finland: evidence for a founder effect. Clin neurol neurosur. A possible spatial and temporal cluster of multiple sclerosis in the town of Linguaglossa, Sicily. High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition.
J Neurol Sci. Multiple sclerosis in Cyprus. New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
Ann Neurol. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Criteria for the clinical diagnosis of multiple sclerosis. Problems of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci. Multiple sclerosis: a reappraisal. Edinburgh: Churchill Livingstone; Diagnosis and classification of multiple sclerosis. Br Med Bull. High prevalence and fast rising incidence of multiple sclerosis in Caltanissetta, Sicily, southern Italy. Prevalence and incidence of multiple sclerosis in Catania, Sicily.
Possible increasing risk of multiple sclerosis in Catania, Sicily. Multiple sclerosis in southern Europe: Monreale City, Italy. A twenty-year follow-up incidence and prevalence study. Incidence of multiple sclerosis in Bagheria City, Sicily, Italy. Neurol Sci. Prevalence and incidence of multiple sclerosis in the city of Monreale, Italy.
Bayesian mapping of multiple sclerosis prevalence in the province of Pavia, northern Italy. Multiple sclerosis in the province of Ferrara: evidence for an increasing trend. Multiple sclerosis in Italy: a reappraisal of incidence and prevalence in Ferrara. Arch Neurol. Epidemiological survey of multiple sclerosis in the provinces of Reggio Emilia and Modena, Italy. Increasing frequency of multiple sclerosis in Padova, Italy: a 30 year epidemiological survey. Multiple sclerosis. The prevalence of multiple sclerosis in the north-west Italian province of Genoa.
An epidemiological study of multiple sclerosis in central Sardinia, Italy.